CHM chimeric therapeutics limited

Ann: 1st patient dosed in CHM 0201 Vactosertib trial, page-6

  1. 14,052 Posts.
    lightbulb Created with Sketch. 4207
    CHM 2101 (CDH17 CAR T)
    Status: waiting for FDA IND clearance
    "Our team has been intensely dedicated in 2022 to completing all of the work necessary to move CHM 2101 into a phase 1 clinical trial as soon as possible."
    - Jennifer Chow, CEO & MD, December 2022

    Pfeifer,

    JC and her team were involved to get 4 out of 6 CD19 CAR-T to the patients, imagine they can do it again with CD17 CAR-T.

    The potential is enormous but market will be unlikely to act until safety and efficacy is demonstrated. But by then the sp won't be sub 10c anymore.

    GLTA
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $8.060M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $28.14K 7.037M

Buyers (Bids)

No. Vol. Price($)
1 243067 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 14771167 22
View Market Depth
Last trade - 15.39pm 20/06/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.